Liothyronine Sodium
NDC 39822-0151, Liothyronine Sodium, injection, solution, from XGen Pharmaceuticals DJB, Inc..
- Product NDC
- 39822-0151
- Status
- Listed
- Labeler
- XGen Pharmaceuticals DJB, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076923
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/39822-0151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM10 ug/mL
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 39822-0151-1 | 39822015101 | 1 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a8b39730-de19-497d-bde8-6594aa528403
Use it
Look up 39822-0151 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/39822-0151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 39822-0151. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.